Página Inicial

Grade


23/09/2021 (Quinta-feira)

  Auditório
19:00 19:00 - 19:05

Dia 23 de setembro

ABERTURA

CLARISSA MATHIAS

Chair

ANA GELATTI

Chair

CARLOS GIL

Chair

BRUNO FERRARI

Chair
19:05 19:05 - 19:45

Pulmão

BLOCO 1 - HIGHLIGHTS: SCREENING / TABAGISMO / EPIDEMIOLOGIA / PESQUISA

MARIANA LALONI

Chair

CLARISSA MATHIAS

Debatedora

19:05 - 19:10
PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution

ELEAN GIUSTI

Palestrante

19:10 - 19:15
PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

PEDRO NAZARETH AGUIAR JUNIOR

SAO PAULO / SP Palestrante

19:15 - 19:20
PL03.02 - Lung Cancer Screening in Latin America: Current Status and Challenges

BRUNO HOCHHEGGER

PORTO ALEGRE / RS Palestrante

19:20 - 19:45
Discussão

19:45 19:45 - 20:15

Pulmão

BLOCO 2 - HIGHLIGHTS: ESTADIO I-II

TATIANE MONTELLA

Chair

RICARDO OLIVEIRA

- / - Debatedor

MARIA TERESA TSUKAZAN

Debatedora

FLÁVIA AMARAL

Debatedora

19:45 - 19:50
PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Tye and Extend of Therapy Prior to Adjuvant Atezolizumab

MARINA KELNER

RECIFE / PE Palestrante

19:50 - 19:55
OA11.01 - Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer

19:55 - 20:00
OA11.03 - Survival and Prognostic Factors of Resected T3N0M0 NSCLC

DANIEL BONOMI

Palestrante

20:00 - 20:15
Discussão

20:15 20:15 - 20:35

Pulmão

Aula Magna

MARIANO ZALIS

Chair

20:15 - 20:30
Atualizações sobre biópsia líquida em câncer de pulmão

RODRIGO DIENSTMANN

SAO PAULO / SP Palestrante
20:35  

Legenda

  • Dia 23 de setembro
  • Pulmão

24/09/2021 (Sexta-feira)

  Auditório
18:55 18:55 - 19:00

Dia 24 de setembro

ABERTURA

CLARISSA MATHIAS

Chair

ANA GELATTI

Chair
19:00 19:00 - 19:30

Pulmão

BLOCO 3 - HIGHLIGHTS ESTADIO III e IV (imunoterapia)

ANA GELATTI

Chair

RAFAEL LESSA

Debatedor

VINICIUS LORANDI

PORTO ALEGRE / RS Debatedor

19:00 - 19:05
OA11.04 - Impact of Local Control on Cause-Specific Survival After SBRT for Early-Stage NSCLC: Dynamic Prediction With Landmarking

THARCISIO COELHO

Palestrante

19:05 - 19:10
PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

FLÁVIA AMARAL

Palestrante

19:10 - 19:15
OA09.01 - First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA

JULIANO CE

Palestrante

19:15 - 19:20
OA09.03 - Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

TERCIA REIS

Palestrante

19:20 - 19:30
Discussão

19:30 19:30 - 20:00

Pulmão

BLOCO 4 - HIGHLIGHTS: ESTADIO IV (terapia alvo) e DOENÇA OLIGOMETASTÁTICA

JACQUES TABACOF

SAO PAULO / SP Chair

JEAN PEREIRA

JOAO PESSOA / PB Debatedor

ELGE WERNECK

Debatedor

19:30 - 19:35
OA15.03 - Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

VINICIUS LORANDI

PORTO ALEGRE / RS Palestrante

19:35 - 19:40
OA15.04 - Telisotuzumab Vedotin (teliso-v) Monotherapy in Patients With Previously Treated c-Met+ Advanced Non-Small Cell Lung Cancer

DENISE LEITE

SAO PAULO / SP Palestrante

19:40 - 19:45
§  MA01.01 - The Role of Surgery for M1a Non-Small-Cell Lung Cancer with Contralateral Lung Involvement

JOÃO DUTRA

Palestrante

19:45 - 19:50
MA01.02 - Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer

MARIA TERESA TSUKAZAN

Palestrante

19:50 - 20:00
Discussão

20:00 20:00 - 20:35

Pulmão

Aulas Magnas

CARLOS GIL

Chair

20:00 - 20:15
O que o WCLC 2021 muda na Cirurgia?

PAULA UGALDE

BOSTON / MA Palestrante

20:15 - 20:30
O que o WCLC 2021 muda na Oncologia Clínica?

TATIANE MONTELLA

Palestrante
20:35  

Legenda

  • Dia 24 de setembro
  • Pulmão